Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease in Adults With Nodular Bronchiectasis (CleaR-MAC Trial)

NCT04616924 is registered in ClinicalTrials.gov with RedHill Biopharma Limited as lead sponsor.

NCT NCT04616924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04616924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease in Adults With Nodular Bronchiectasis (CleaR-MAC Trial)
Lead sponsor
RedHill Biopharma Limited
Phase
Phase 3
Overall status
Terminated
Start date
December 1, 2020
Completion date
August 28, 2023
Enrollment
12 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis, lung diseases, pulmonary mycobacterium avium complex infection